This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Geron Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations by JianJie Jiang in Stem Cell Research
Introduction
JianJie Jiang is a notable inventor based in Sunnyvale, CA, who has made significant contributions to the field of stem cell research. His work focuses on the differentiation and enrichment of islet-like cells from human pluripotent stem cells. With a keen interest in advancing medical science, Jiang has developed methods that could potentially lead to breakthroughs in diabetes treatment.
Latest Patents
Jiang holds a patent titled "Differentiation and enrichment of islet-like cells from human pluripotent stem cells." This patent outlines methods for differentiating human pluripotent stem cells into islet-like cells. The methods involve sequential culturing of the stem cells with specific factors to produce islet-like cells. Additionally, the population of cells produced can be further enriched for islet-like cells, enhancing their potential for therapeutic applications. He has 1 patent to his name.
Career Highlights
Jiang is currently employed at Geron Corporation, a company known for its pioneering work in regenerative medicine and stem cell therapy. His role at Geron allows him to collaborate with other experts in the field and contribute to innovative research projects that aim to improve patient outcomes.
Collaborations
Throughout his career, Jiang has worked alongside talented colleagues, including Anish Sen Majumdar and Melinda Au. These collaborations have fostered a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
JianJie Jiang's contributions to stem cell research, particularly in the differentiation of islet-like cells, highlight his innovative spirit and dedication to advancing medical science. His work has the potential to impact the treatment of diabetes and improve the lives of many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
